Taysha Gene Therapies (TSHA) Earnings Date, Estimates & Call Transcripts $4.75 -0.19 (-3.85%) Closing price 04:00 PM EasternExtended Trading$4.76 +0.00 (+0.11%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Taysha Gene Therapies Earnings Summary Taysha Gene Therapies announced Q2 2025 earnings on August 12, 2025, reporting an EPS of -$0.09, which missed analysts' consensus estimates of -$0.07 by $0.02. Quarterly revenue was reported to be $1.99 million, above analyst estimates of $1.61 million. With a trailing EPS of -$0.34, Taysha Gene Therapies' earnings are expected to decrease next year, from ($0.35) to ($0.37) per share. Upcoming Q3 Earnings DateNov. 12Before Market OpensEstimatedConsensus EPS (Aug. 12) -$0.07 Actual EPS (Aug. 12) -$0.09 Missed By -$0.02 Actual Revenue (Aug. 12) $1.99MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)TSHA Upcoming EarningsTaysha Gene Therapies' Q3 2025 earnings is scheduled for Wednesday, November 12, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2025 Earnings ReportPowered by Get Taysha Gene Therapies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Taysha Gene Therapies and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataTSHA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TSHA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Taysha Gene Therapies Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($0.35) EPSNext Year EPS Consensus Estimate ($0.37) EPS Taysha Gene Therapies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/12/2025(Estimated)-------8/12/2025Q2 2025-$0.07-$0.09 -$0.02-$0.09$1.61M$1.99M5/15/2025Q1 2025-$0.08-$0.08--$0.08$1.48M$2.30M2/26/2025Q4 2024-$0.08-$0.07+$0.01-$0.07$2.05M$2.02M8/12/2024Q2 2024-$0.10-$0.09+$0.01-$0.09$3.62M$1.11M5/14/2024Q1 2024-$0.11-$0.10+$0.01-$0.10$3.70M$3.41M3/19/2024Q4 2023-$0.35--$0.22$4.75M$3.60M11/14/2023Q3 2023-$0.13-$0.13-$0.67$2.65M$4.75M Taysha Gene Therapies Earnings - Frequently Asked Questions When is Taysha Gene Therapies' earnings date? Taysha Gene Therapies has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 12th, 2025 based off last year's report dates. Learn more on TSHA's earnings history. Did Taysha Gene Therapies beat their earnings estimates last quarter? In the previous quarter, Taysha Gene Therapies (NASDAQ:TSHA) missed the analysts' consensus estimate of ($0.07) by $0.02 with a reported earnings per share (EPS) of ($0.09). Learn more on analysts' earnings estimate vs. TSHA's actual earnings. How can I listen to Taysha Gene Therapies' earnings conference call? The conference call for Taysha Gene Therapies' latest earnings report can be listened to online. Listen to Conference Call How can I read Taysha Gene Therapies' conference call transcript? The conference call transcript for Taysha Gene Therapies' latest earnings report can be read online. Read Transcript How much revenue does Taysha Gene Therapies generate each year? Taysha Gene Therapies (NASDAQ:TSHA) has a recorded annual revenue of $8.33 million. How much profit does Taysha Gene Therapies generate each year? Taysha Gene Therapies (NASDAQ:TSHA) has a recorded net income of -$89.30 million. TSHA has generated -$0.34 earnings per share over the last four quarters. What is Taysha Gene Therapies' EPS forecast for next year? Taysha Gene Therapies' earnings are expected to decrease from ($0.35) per share to ($0.37) per share in the next year. More Earnings Resources from MarketBeat Related Companies HHH Earnings Results ARWR Earnings Results ACLX Earnings Results PTGX Earnings Results AKRO Earnings Results KYMR Earnings Results NAMS Earnings Results PRAX Earnings Results CRNX Earnings Results LNTH Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Freeport-McMoRan Posts Strong Earnings Despite Indonesia ShutdownTesla’s Earnings Review: Does the Juice Justify the Squeeze?Fal.Con Europe Could Be CrowdStrike’s Early Earnings CatalystLogitech Eyes Breakout Before Earnings—Citigroup Sees 30% UpsideLouis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetGoldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings This page (NASDAQ:TSHA) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersMy starkest warning in years Porter Stansberry — founder of one of the world’s largest financial research firms — believes we’re entering a...Porter & Company | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taysha Gene Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSHA Stock Alerts